Financial incentives to Medicaid smokers for engaging tobacco quit line treatment: maximising return on investment
- PMID: 31147478
- PMCID: PMC8225401
- DOI: 10.1136/tobaccocontrol-2018-054811
Financial incentives to Medicaid smokers for engaging tobacco quit line treatment: maximising return on investment
Abstract
Background: Low-income smokers experience greater difficulty in quitting smoking than do other smokers. Providing financial incentives for treatment engagement increases smoking cessation success. This study models the cost-effectiveness of varying levels of financial incentives to maximise return on investment (ROI) for engaging low-income Medicaid recipients who smoke to take calls from a tobacco quit line.
Methods: Participants (N=1900) were recruited from May 2013 to June 2015 through quit line-based (n=980), clinic-based (n=444) or community-based referrals (n=476) into the Wisconsin Medicaid Quit Line Incentive project. Incentive (n=948) and control group participants (n=952) received $30 versus $0 per call, respectively, for taking up to five Wisconsin Tobacco Quit Line (WTQL) calls. Cost-effectiveness analyses estimated the incremental cost-effectiveness ratio for alternative financial incentives for engagement with WTQL calls. Probabilistic sensitivity analysis was employed to determine an optimal strategy for financial incentives to minimise the cost per individual who quit smoking.
Results: Using fixed payments, the incremental cost-effectiveness ratio of $2316 per smoker who quit in the randomised trial decreased to $2150 per smoker who quit when the incentives were modelled at $20 per each of five WTQL calls taken. Using variable payments, the minimal cost per additional smoker who quit was $2125 when incentives for the first four WTQL calls were set at $20, and the financial payment for the fifth WTQL call was set at $70.
Conclusions: Modelling suggests that financial incentives in the amount of $20 per call for taking the first four quit line calls and $70 for taking a fifth quit line call maximise ROI to engage low-income smokers with evidence-based smoking cessation treatment.
Keywords: cessation; economics; socioeconomic status.
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Figures
Similar articles
-
Paying Low-Income Smokers to Quit? The Cost-Effectiveness of Incentivizing Tobacco Quit Line Engagement for Medicaid Recipients Who Smoke.Value Health. 2019 Feb;22(2):177-184. doi: 10.1016/j.jval.2018.08.001. Epub 2018 Sep 20. Value Health. 2019. PMID: 30711062 Free PMC article. Clinical Trial.
-
A Randomized Trial of Incentives for Smoking Treatment in Medicaid Members.Am J Prev Med. 2017 Dec;53(6):754-763. doi: 10.1016/j.amepre.2017.08.027. Epub 2017 Nov 2. Am J Prev Med. 2017. PMID: 29079405 Free PMC article. Clinical Trial.
-
Economic Impact of Financial Incentives and Mailing Nicotine Patches to Help Medicaid Smokers Quit Smoking: A Cost-Benefit Analysis.Am J Prev Med. 2018 Dec;55(6 Suppl 2):S148-S158. doi: 10.1016/j.amepre.2018.08.007. Am J Prev Med. 2018. PMID: 30454669
-
Motivational support intervention to reduce smoking and increase physical activity in smokers not ready to quit: the TARS RCT.Health Technol Assess. 2023 Mar;27(4):1-277. doi: 10.3310/KLTG1447. Health Technol Assess. 2023. PMID: 37022933 Free PMC article.
-
The use and impact of incentives in population-based smoking cessation programs: a review.Am J Health Promot. 1998 May-Jun;12(5):307-20. doi: 10.4278/0890-1171-12.5.307. Am J Health Promot. 1998. PMID: 10181140 Review.
Cited by
-
Psychological Therapies Used for the Reduction of Habitual Cigarette Smoking Cigarette Consumption: A Systematic Review.Int J Environ Res Public Health. 2024 Jun 9;21(6):753. doi: 10.3390/ijerph21060753. Int J Environ Res Public Health. 2024. PMID: 38929001 Free PMC article.
-
Smoking Cessation Programs Are Less Effective in Smokers with Low Socioeconomic Status Even When Financial Incentives for Quitting Smoking Are Offered-A Community-Randomized Smoking Cessation Trial in Denmark.Int J Environ Res Public Health. 2022 Aug 31;19(17):10879. doi: 10.3390/ijerph191710879. Int J Environ Res Public Health. 2022. PMID: 36078595 Free PMC article. Clinical Trial.
-
Active referral plus a small financial incentive upon cessation services use on smoking abstinence: a community-based, cluster-randomised controlled trial.Lancet Reg Health West Pac. 2021 Jul 5;13:100189. doi: 10.1016/j.lanwpc.2021.100189. eCollection 2021 Aug. Lancet Reg Health West Pac. 2021. PMID: 34527982 Free PMC article.
References
-
- Jamal A, King BA, Neff LJ, Whitmill J, Babb SD, Graffunder CM. Current Cigarette Smoking Among Adults - United States, 2005–2015. MMWR 2016;65(44):1205–1211. - PubMed
-
- Kotz D, West R. Explaining the social gradient in smoking cessation: it’s not in the trying, but in the succeeding. Tob Control. February 2009;18(1):43–46. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous